QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

BBOT

QT59BridgeBio Oncology Therapeutics Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
7.56
-0.12-1.56%
OverviewShort InterestFilings
BBOTQT59BridgeBio Oncology Therapeutics Inc.·NASDAQ
OverviewShort InterestFilings
7.56-1.56%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own31.76%
Shs Outstand80.11M
Perf Week1.34%
Market Cap615.22MForward P/E-EPS next Y-2.14Insider Trans0.00%Shs Float-Perf Month-13.30%
Enterprise Value565.21MPEG0.02EPS next Q-0.54Inst Own-Short Float-Perf Quarter-16.46%
Income-396326373.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y-36.20%
Sales-P/B0.64EPS next Y4.50%ROA-36.90%Short Interest-Perf YTD-39.62%
Book/sh4.64P/C-EPS next 5Y-ROE-61.49%52W High14.87 -49.16%Perf Year-30.64%
Cash/sh3.15P/FCF-EPS past 3/5Y-ROIC-45.04%52W Low7.00 8.00%Perf 3Y-
Dividend Est.-EV/EBITDA-3.36Sales past 3/5Y-Gross Margin0.00%Volatility3.64% 4.27%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-434.30%Oper. Margin0.00%ATR (14)0.52Perf 10Y-
Dividend Ex-Date-Quick Ratio6.16Sales Y/Y TTM-Profit Margin0.00%RSI (14)40.77Recom2.00
Dividend Gr. 3/5Y-Current Ratio6.16EPS Q/Q-548.13%SMA20-6.28%Beta1.15Target Price22.00
Payout0.00%Debt/Eq0.01Sales Q/Q-SMA50-10.10%Rel Volume5.03Prev Close7.68
Employees62LT Debt/Eq0.00EarningsSep 02SMA200-28.36%Avg Volume456.32KPrice7.56
IPO DateAug 12, 2025Option/ShortYes / YesEPS/Sales Surpr.-2.76% -Net Debt/EBITDA0.30Volume2,293,216Change-1.56%
Analyst Ratings
DateActionAnalystRatingTarget
May-11-26InitiatedCanaccordBuy$23
Feb-10-26InitiatedStifelBuy$23
Jan-09-26InitiatedRaymond JamesOutperform$24
Jan-08-26ReiteratedMorgan Stanley$20 → $18
Dec-05-25InitiatedMorgan StanleyOverweight$20
Sep-17-25InitiatedLeerinkOutperform$25
Sep-15-25InitiatedH.CBuy$27
Sep-04-25InitiatedOppenheimerOutperform$23
Aug-15-25InitiatedPiper SandlerOverweight$21
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A
000
Gross Profit
000
Selling, General and Administrative Excl. Other2588
Research and Development1217356
Other Operating Expense001
Operating Income-146-81-65
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)
000
Net Income Before Taxes-134-74-65
Income Taxes
000
Consolidated Net Income-134-74-65
Net Income From Continuing Operations-1348-65
Net Income-134-74-65
EPS (Recurring)-4.300.46-3.16
EPS (Basic, Before Extraordinaries)-4.300.46-3.16
EPS (Diluted)-4.300.46-3.16
EBITDA-145-81-65
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding311720
Market Capitalization388——
Operating Lease Expense
———
Insider Trading Volume
$7.88$7.38$6.88$6.38$5.88● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Chen Bihuadirector, 10 percent owner:Aug 11 '25Option Exercise0.008,344,2524174,681,126Aug 13 12:00 AM
Holman Albert A IIIother: Former DirectorAug 11 '25Option Exercise0.0060,000030,000Aug 11 12:00 AM
McKenna Mark C.other: Former DirectorAug 11 '25Option Exercise0.0060,000030,000Aug 11 12:00 AM
Schmid John P.other: Former DirectorAug 11 '25Option Exercise0.0060,000030,000Aug 11 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR